Up to date evidence-based review of medicinal mushrooms in cancer, including:
- A novel mushroom extract that can be used as an alternative to patients who are intolerant to or refuse endocrine therapy for breast and prostate cancers
- Significant differences in quality and quantity of clinical trials for various mushroom extracts
- Useful tables to refer to in decision-making for which mushroom extracts to recommend in common cancers
- Potential toxicity of medicinal mushrooms
- Synergy of different mushroom extracts
- Psilocybin for cancer-related distress
Dr Michael Traub, ND, DHANP, CCH, FABNO
Dr Michael Traub obtained his undergraduate degree in biological sciences from the University of California, Irvine in 1976 where he conducted neurobiology research of learning and memory for Professor James L. McGaugh. He graduated from the National College of Naturopathic Medicine in 1981 and completed a residency there in Family Practice and Homeopathy.
He became board certified in homeopathic medicine by the Homeopathic Academy of Naturopathic Physicians in 1989. Dr Traub was recognized for his many years of service to the American Association of Naturopathic Physicians, including President from 2001-2003, when he was honored with the 2006 Physician of the Year Award. His father was a dermatologist, and this inspired Dr Traub to undertake extra study in this subject. He has taught dermatology at five of the seven accredited naturopathic medical schools in North America and is the author of “Essentials of Dermatologic Diagnosis and Integrative Therapeutics.” He is a recognized authority in the naturopathic profession on dermatology. He serves on the scientific advisory boards of several natural product companies, and has been actively engaged in clinical research for most of his career. Dr Traub has been medical director of Lokahi Health Center in Kailua Kona, Hawaii for the past 37 years. He is also board certified in naturopathic oncology by the American Board of Naturopathic Oncology.
